Table V.

Recommendations on tests to perform in all neonates.

Rec. n.	Recommendation	GoR
13	It is suggested that a DAT is carried out on a sample of cord blood of all neonates. In the event of a positive DAT and in the presence of clinical signs of HDFN, it is suggested that the antibody is eluted from the cord blood red cells, in order to confirm the antibody’s specificity.	2C
14	In neonates of RhD negative mothers, it is suggested that the same sample of cord blood used for the DAT is used to determine the RhD phenotype, with methods capable of also detecting the weak D phenotype and at least its most common variant, DVI.	2C